Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

OpenAI and Google revealed fresh AI breakthroughs showing different technology paths in artificial intelligence research. Companies are battling to control how ...

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Quantum startup SandboxAQ said its large quantitative models (LQMs) will be available on Google Cloud, the company told ...

Google is making a fresh investment of more than $1 billion into AI startup Anthropic, the Financial Times reported on ...

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with ...

“If you use a Google maps analogy,” explains Alex Ward, PhD, co-founder of Tolemy Bio. “Then we’re bypassing bottlenecks in ...

The new tranche of money from Google into Anthropic adds to a total investment of $8 billion from Amazon, the ecommerce group ...

At the heart of Google’s multimodal AI strategy is BigQuery, a data warehouse that the company is repositioning as a data ...

An AI judge gets a tryout during the X Games this week in Aspen, Colorado. The experimental Google Cloud-based tech will ...

Google Shopping has new AI features to let ... are bracing for the unpredictable and emergent threat posed by artificial intelligence, or AI. AI companies capable of generating creative content ...